Art Unit 1622
Group 1620Biomedicinal Chemistry
- Active examiners
- 39
- Average office actions per grant
- 1.57
Grant ratio
- Art Unit 1622
- 69.1%
- Group 1620
- 61.2%
Active examiners
| Kristin Ann Vajda | 70.3% | 1.31 | October 2026 |
|---|---|---|---|
| Yate' K. Cutliff | 84.0% | 1.46 | October 2026 |
| Bruck Kifle | 75.2% | 1.54 | October 2026 |
| Taylor V Oh | 78.9% | 1.67 | October 2026 |
| Sikarl Witherspoon | 92.3% | 1.29 | October 2026 |
| Jafar Parsa | 91.5% | 1.14 | September 2026 |
| Deborah D. Carr | 82.4% | 1.37 | September 2026 |
| Sun Jae Yoo | 67.2% | 2.23 | October 2026 |
| Amy C Bonaparte | 79.4% | 1.65 | September 2026 |
| Erich A. Leeser | 64.2% | 1.27 | October 2026 |
| Clinton Brooks | 77.7% | 2.03 | October 2026 |
| Lauren Wells | 23.7% | 2.06 | September 2026 |
| Medhanit W Bahta | 82.6% | 1.97 | October 2026 |
| Ana Z Muresan | 77.5% | 1.65 | October 2026 |
| Alexander R Pagano | 81.4% | 1.61 | September 2026 |
| Golam Shameem, Ph.D | 84.7% | 1.14 | September 2026 |
| Blaine G Doletski | 76.5% | 1.70 | October 2026 |
| Noble Jarrell | 79.3% | 1.71 | October 2026 |
| Valerie Rodriguez-Garcia | 65.4% | 1.68 | October 2026 |
| John S Kenyon | 77.4% | 1.83 | October 2026 |
| Manahil Mirghani Ali Abdalhameed | 28.2% | 1.77 | October 2026 |
| Paul V. Ward | 27.8% | 1.37 | October 2026 |
| Jennifer Cho Sawyer | 76.0% | 1.81 | October 2026 |
| Pierre Paul Eleniste | 11.1% | 2.73 | October 2026 |
| Layla Soroush | 13.2% | 2.76 | October 2026 |
| Carolyn L. Ladd | 19.0% | 1.29 | October 2026 |
| Sahar Javanmard | 6.3% | 1.71 | September 2026 |
| Chantal Adlam | 16.7% | 1.93 | September 2026 |
| Chris E Simmons | 9.3% | 2.75 | October 2026 |
| Justin Christopher Sanchez | 22.9% | 1.30 | October 2026 |
| Frank S. Hou | 69.4% | 1.81 | September 2026 |
| Karen Cheng | 71.0% | 1.52 | October 2026 |
| Allen Chao | 0.0% | N/A | October 2026 |
| Madeline M Dekarske | 0.0% | N/A | October 2026 |
| Robert Havlin | 97.1% | 2.39 | October 2026 |
| Andrew D. Kosar | 3.0% | 1.45 | October 2026 |
| Brandon J. Fetterolf | 43.5% | 1.65 | September 2026 |
| Sahar Inam | 0.0% | N/A | October 2026 |
| Kara R. Mcmillian | 0.0% | 2.69 | October 2026 |
Examiner distribution
- Median grant ratio
- 69.9%
- Middle 50% of grant ratios
- 20.0%–79.2%
- Median office actions / grant
- 1.67
- Middle 50% of office actions / grant
- 1.41–1.88
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Taofiq A. Solola, Phd. Jd | 73.8% | 1.51 | May 2026 Potentially inactive |
|---|---|---|---|
| Raymond Covington | 73.3% | 1.46 | August 2015 Appears inactive |
| Paul A. Zucker | 90.5% | 1.44 | December 2020 Appears inactive |
| Mark L. Berch | 51.8% | 1.83 | December 2012 Appears inactive |
| Laura Daniel | 69.6% | 1.96 | November 2020 Appears inactive |
| Bernard Dentz | 76.9% | 1.23 | July 2013 Appears inactive |
| Heidi Reese | 92.2% | 1.59 | March 2022 Appears inactive |
| John M. Mauro | 67.2% | 1.48 | November 2024 Appears inactive |
| Mark Luderer | 89.2% | 1.49 | June 2019 Appears inactive |
| Rosalynd Keys | 67.6% | 2.01 | November 2024 Appears inactive |
| Kofi Adzamli | 86.1% | 1.27 | October 2023 Appears inactive |
| James H. Alstrum-Acevedo | 0.0% | 2.40 | April 2026 Potentially inactive |
Based on available public USPTO records; may be incomplete.